Zealand Pharma As Stock Filter Stocks by Fundamentals
ZEAL Stock | DKK 581.50 2.00 0.34% |
Zealand Pharma AS fundamentals help investors to digest information that contributes to Zealand Pharma's financial success or failures. It also enables traders to predict the movement of Zealand Stock. The fundamental analysis module provides a way to measure Zealand Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Zealand Pharma stock.
Zealand |
Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
All Next | Launch Module |
Zealand Fundamentals
Return On Equity | -1.44 | |||
Return On Asset | -0.48 | |||
Operating Margin | (3.82) % | |||
Current Valuation | 10.33 B | |||
Shares Outstanding | 51.28 M | |||
Shares Owned By Insiders | 0.07 % | |||
Shares Owned By Institutions | 56.21 % | |||
Price To Earning | 12.66 X | |||
Price To Book | 27.77 X | |||
Price To Sales | 36.73 X | |||
Revenue | 292.57 M | |||
Gross Profit | 173.75 M | |||
EBITDA | (982.6 M) | |||
Net Income | (1.02 B) | |||
Cash And Equivalents | 1.28 B | |||
Cash Per Share | 29.66 X | |||
Total Debt | 647.91 M | |||
Debt To Equity | 0.10 % | |||
Current Ratio | 4.19 X | |||
Book Value Per Share | 7.91 X | |||
Cash Flow From Operations | (1.21 B) | |||
Earnings Per Share | (23.13) X | |||
Price To Earnings To Growth | 0.31 X | |||
Target Price | 243.75 | |||
Number Of Employees | 203 | |||
Beta | 0.95 | |||
Market Capitalization | 11.16 B | |||
Total Asset | 2.07 B | |||
Retained Earnings | 154 M | |||
Working Capital | 463 M | |||
Current Asset | 517 M | |||
Current Liabilities | 54 M | |||
Z Score | 10.2 | |||
Net Asset | 2.07 B |
About Zealand Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zealand Pharma AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zealand Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zealand Pharma AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zealand Pharma AS. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Zealand Stock analysis
When running Zealand Pharma's price analysis, check to measure Zealand Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zealand Pharma is operating at the current time. Most of Zealand Pharma's value examination focuses on studying past and present price action to predict the probability of Zealand Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zealand Pharma's price. Additionally, you may evaluate how the addition of Zealand Pharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |